{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T18:35:56Z","timestamp":1764873356416,"version":"3.37.3"},"reference-count":44,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2015,5,5]],"date-time":"2015-05-05T00:00:00Z","timestamp":1430784000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"NovoNordisk"},{"name":"Above and Beyond Charitable Trustees"},{"name":"Merck Serono"},{"DOI":"10.13039\/501100014382","name":"Ipsen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100014382","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[2015,10]]},"abstract":"<jats:title>Summary<\/jats:title><jats:sec><jats:title>Objective<\/jats:title><jats:p>Bone marrow transplantation with total body irradiation (<jats:styled-content style=\"fixed-case\">BMT<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">TBI<\/jats:styled-content>) has adverse effects on growth, growth hormone status and adiposity. We investigated the <jats:styled-content style=\"fixed-case\">GH<\/jats:styled-content>\u2013<jats:styled-content style=\"fixed-case\">IGF<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">I<\/jats:styled-content> axis in relation to adiposity.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>Cross\u2010sectional case control study.<\/jats:p><\/jats:sec><jats:sec><jats:title>Patients<\/jats:title><jats:p><jats:styled-content style=\"fixed-case\">BMT<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">TBI<\/jats:styled-content> survivors (<jats:italic>n<\/jats:italic>\u00a0=\u00a022) and short stature control participants (<jats:italic>n<\/jats:italic>\u00a0=\u00a019), all <jats:styled-content style=\"fixed-case\">GH<\/jats:styled-content>\u2010na\u00efve or off <jats:styled-content style=\"fixed-case\">GH<\/jats:styled-content> treatment &gt;3\u00a0months.<\/jats:p><\/jats:sec><jats:sec><jats:title>Measurements<\/jats:title><jats:p>Auxology, <jats:styled-content style=\"fixed-case\">DEXA<\/jats:styled-content> scans and <jats:styled-content style=\"fixed-case\">GH<\/jats:styled-content>\u2013<jats:styled-content style=\"fixed-case\">IGF<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">I<\/jats:styled-content> axis investigation: (i) 12\u2010h overnight <jats:styled-content style=\"fixed-case\">GH<\/jats:styled-content> profiles; (ii) insulin tolerance test (<jats:styled-content style=\"fixed-case\">ITT<\/jats:styled-content>); and (iii) <jats:styled-content style=\"fixed-case\">IGF<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">I<\/jats:styled-content> generation test. Analysis: auto\u2010deconvolution of <jats:styled-content style=\"fixed-case\">GH<\/jats:styled-content> profile data and comparison of quantitative parameters using <jats:sc>anova<\/jats:sc>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Eighty\u2010two percent of <jats:styled-content style=\"fixed-case\">BMT<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">TBI<\/jats:styled-content> survivors had growth hormone deficiency (<jats:styled-content style=\"fixed-case\">GHD<\/jats:styled-content>) using <jats:styled-content style=\"fixed-case\">ITT<\/jats:styled-content>. <jats:styled-content style=\"fixed-case\">GH<\/jats:styled-content> profile area\u2010under\u2010the\u2010curve (<jats:styled-content style=\"fixed-case\">GH<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">AUC<\/jats:styled-content>) was reduced in <jats:styled-content style=\"fixed-case\">BMT<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">TBI<\/jats:styled-content> survivors <jats:italic>vs<\/jats:italic> short stature control participants [geometric mean (range) 209 (21\u2013825) <jats:italic>vs<\/jats:italic> 428 (64\u20131400) mcg\/l\/12\u00a0h, respectively, <jats:italic>P\u00a0<\/jats:italic>=<jats:italic>\u00a0<\/jats:italic>0\u00b7007]. <jats:styled-content style=\"fixed-case\">GHD<\/jats:styled-content> was more marked in those who had additional cranial irradiation (<jats:styled-content style=\"fixed-case\">CRT<\/jats:styled-content>) [<jats:styled-content style=\"fixed-case\">ITT<\/jats:styled-content> peak 1\u00b74 (0\u00b72\u20133\u00b70) <jats:italic>vs <\/jats:italic><jats:styled-content style=\"fixed-case\">TBI<\/jats:styled-content> only 4\u00b71 (1\u00b71\u201314\u00b78) mcg\/l, <jats:italic>P<\/jats:italic>\u00a0=\u00a00\u00b7036]. <jats:styled-content style=\"fixed-case\">GHD<\/jats:styled-content> was more marked at the end of growth in <jats:styled-content style=\"fixed-case\">BMT<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">TBI<\/jats:styled-content> survivors <jats:italic>vs<\/jats:italic> short stature control participants (<jats:styled-content style=\"fixed-case\">GH<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">AUC<\/jats:styled-content> 551 (64\u20132474) <jats:italic>vs<\/jats:italic> 1369 (192\u20134197) mcg\/l\/12\u00a0h, respectively, <jats:italic>P<\/jats:italic>\u00a0=\u00a00\u00b7011) and more prevalent (9\/11 <jats:italic>vs<\/jats:italic> 1\/9, respectively, <jats:italic>P<\/jats:italic>\u00a0=\u00a00\u00b7005). <jats:styled-content style=\"fixed-case\">GH<\/jats:styled-content> profile data were consistent with <jats:styled-content style=\"fixed-case\">ITT<\/jats:styled-content> results in 80% of participants. <jats:styled-content style=\"fixed-case\">IGF<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">I<\/jats:styled-content> generation tests were normal. <jats:styled-content style=\"fixed-case\">BMT<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">TBI<\/jats:styled-content> survivors still demonstrated lower <jats:styled-content style=\"fixed-case\">GH<\/jats:styled-content> levels after adjustment for adiposity (fat\u2010adjusted mean difference for <jats:styled-content style=\"fixed-case\">GH<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">AUC<\/jats:styled-content> 90\u00b79\u00a0mcg\/l\/12\u00a0h, <jats:italic>P<\/jats:italic>\u00a0=\u00a00\u00b7025).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p><jats:styled-content style=\"fixed-case\">GHD<\/jats:styled-content> was more prevalent in <jats:styled-content style=\"fixed-case\">BMT<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">TBI<\/jats:styled-content> survivors than expected for the <jats:styled-content style=\"fixed-case\">CRT<\/jats:styled-content> dose in <jats:styled-content style=\"fixed-case\">TBI<\/jats:styled-content>, worsened with time and persisted into adulthood. <jats:styled-content style=\"fixed-case\">GHD<\/jats:styled-content> could not be explained by adiposity. There was no evidence of <jats:styled-content style=\"fixed-case\">GH<\/jats:styled-content> neurosecretory dysfunction or resistance after <jats:styled-content style=\"fixed-case\">BMT<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">TBI<\/jats:styled-content>.<\/jats:p><\/jats:sec>","DOI":"10.1111\/cen.12773","type":"journal-article","created":{"date-parts":[[2015,3,24]],"date-time":"2015-03-24T15:47:47Z","timestamp":1427212067000},"page":"508-517","source":"Crossref","is-referenced-by-count":14,"title":["Growth hormone deficiency after childhood bone marrow transplantation with total body irradiation: interaction with adiposity and age"],"prefix":"10.1111","volume":"83","author":[{"given":"N.L.","family":"Davis","sequence":"first","affiliation":[{"name":"Department of Paediatric Endocrinology and Diabetes University Hospitals Bristol NHS Foundation Trust Bristol UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.E.","family":"Stewart","sequence":"additional","affiliation":[{"name":"Department of Stem Cells Ageing and Molecular Physiology Unit Research Institute for Sport &amp; Exercise Sciences Liverpool John Moores University Liverpool UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.D.","family":"Moss","sequence":"additional","affiliation":[{"name":"Department of Exercise and Sport Science Manchester Metropolitan University Crewe Cheshire UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.W.W.","family":"Woltersdorf","sequence":"additional","affiliation":[{"name":"Department of Paediatric Endocrinology and Diabetes University Hospitals Bristol NHS Foundation Trust Bristol UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.P.","family":"Hunt","sequence":"additional","affiliation":[{"name":"School of Clinical Sciences University of Bristol Bristol UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.A.","family":"Elson","sequence":"additional","affiliation":[{"name":"Department of Paediatric Endocrinology and Diabetes University Hospitals Bristol NHS Foundation Trust Bristol UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.","family":"Cornish","sequence":"additional","affiliation":[{"name":"Department of Paediatric Oncology University Hospitals Bristol NHS Foundation Trust Bristol UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.C.G.","family":"Stevens","sequence":"additional","affiliation":[{"name":"School of Clinical Sciences University of Bristol Bristol UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.C.","family":"Crowne","sequence":"additional","affiliation":[{"name":"Department of Paediatric Endocrinology and Diabetes University Hospitals Bristol NHS Foundation Trust Bristol UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2015,5,5]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1704324"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1159\/000207607"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.78.3.597"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1159\/000067834"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s004310050006"},{"key":"e_1_2_8_7_1","first-page":"4109","article-title":"Final height of patients who underwent bone marrow transplantation for hematological disorders during childhood: a study by the Working Party for Late Effects\u2010EBMT","volume":"93","author":"Cohen A.","year":"1999","journal-title":"Blood"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.1360331"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-1525"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.1500329"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V86.2.819.bloodjournal862819"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1159\/000064768"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.1570225"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1136\/adc.70.6.472"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ghir.2007.04.010"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.81.7.2460"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-73-2-428"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijo.0800807"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-0128"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-2599"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1136\/adc.66.6.689"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejon.2004.08.006"},{"key":"e_1_2_8_23_1","first-page":"163","article-title":"Growth, growth hormone and final height after BMT. Possible recovery of irradiation\u2010induced growth hormone insufficiency","volume":"18","author":"Holm K.","year":"1996","journal-title":"Bone Marrow Transplantation"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1136\/adc.62.5.461"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705374"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1530\/eje.1.01931"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2008.03283.x"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ejcn.1601240"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1136\/adc.51.3.170"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0258(19980228)17:4<407::AID-SIM742>3.0.CO;2-L"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2007.10.008"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2003.01986.x"},{"issue":"3","key":"e_1_2_8_33_1","first-page":"237","article-title":"New modalities for understanding dynamic regulation of the somatotropic (GH) axis: explication of gender differences in GH neuroregulation in the human","volume":"9","author":"Veldhuis J.D.","year":"1996","journal-title":"Journal of Pediatric Endocrinology and Metabolism"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ab.2008.07.001"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.2001.281.6.R1975"},{"volume-title":"Essentials of Medical Statistics","year":"2003","author":"Kirkwood B.","key":"e_1_2_8_36_1"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2009.08.017"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-2002"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-73-5-1081"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.1981.tb07177.x"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncpendmet1051"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2004.02149.x"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1703012"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/434562"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.1210\/er.19.6.717"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcen.12773","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcen.12773","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cen.12773","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T09:35:01Z","timestamp":1695548101000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/cen.12773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,5]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["10.1111\/cen.12773"],"URL":"https:\/\/doi.org\/10.1111\/cen.12773","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"type":"print","value":"0300-0664"},{"type":"electronic","value":"1365-2265"}],"subject":[],"published":{"date-parts":[[2015,5,5]]}}}